Eevia Health Plc received a 168 kSEK / 15 kEUR order for a rapeseed extract.
Eevia Health Plc, (”Eevia” or ”The Company”), has received a sales order from a Finnish food company for a custom made rapeseed extract for the value of 15 kEUR (168 kSEK).
The customer is a large food ingredient manufacturer, and a significant producer of vegetable and rapeseed oils. Their main markets for are Finland and the other Nordic countries.
Eevia will fulfill this order by extracting a custom-made rapeseed extract based. The order is based an exclusive frame agreement for this product. The order is expected to create repeat sales of this product going forward.
For further information, please contact:
Stein Ulve, CEO, Eevia Health Plc
Email: [email protected] or [email protected]
Telephone: +358 400 22 5967
INFORMATION ABOUT EEVIA HEALTH PLC
Eevia Health Plc, founded in March 2017, addresses significant health problems with bioactive compounds extracted from plant materials. The materials are primarily wild-harvested from the pristine Finnish and Swedish forests near or above the Arctic Circle. The extracts are sold B2B as ingredients to dietary supplements and food brands globally. These global brands utilize the ingredients in their consumer product formulas.
Eevia Health is a manufacturer of 100% organically certified plant extracts. Although a significant product; Elderberry extract, is made from cultivated berries, most of Eevia’s other raw materials, such as bilberry, lingonberry, chaga-mushroom, and pine bark, are wild-harvested in a sustainable fashion.
Eevia Health operates a modern green-chemistry production facility in Finland. The factory operates near the raw material harvest areas. A uniquely short value chain enables an environmentally friendly carbon footprint, competitive pricing, and extreme transparency. Eevia listed its shares at Spotlight Stock Market in Sweden in June 2021, with the short name EEVIA.
To learn more, please visit www.eeviahealth.com or follow Eevia Health on LinkedIn @EeviaHealth.
